Fractyl Health Inc.
GUTS | NASDAQ
$0.55
-$0.02 (-3.80%)
Sep 22, 2026, 12:45 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 93K | 120K | n/a | n/a | n/a |
Cost of Revenue | n/a | 50K | 77K | 452K | n/a | 770K |
Gross Profit | n/a | 43K | 43K | -452K | n/a | -770K |
Operating Income | -96.82M | -93.53M | -50.84M | -49.39M | -36.93M | -28.96M |
Interest Income | 1.54M | 4.15M | 1.26M | 797K | n/a | n/a |
Pretax Income | -140.95M | -68.69M | -77.09M | -46.45M | -38.74M | -30.48M |
Net Income | -140.95M | -68.69M | -77.09M | -46.45M | -38.74M | -30.48M |
Selling & General & Admin | 22.28M | n/a | n/a | 14.58M | 10.49M | 5.76M |
Research & Development | 74.54M | 70.47M | 38.04M | 34.35M | 26.44M | 22.43M |
Other Expenses | n/a | 23.1M | 12.84M | n/a | n/a | n/a |
Operating Expenses | 96.82M | 93.57M | 50.88M | 48.93M | 36.93M | 28.19M |
Interest Expense | n/a | n/a | n/a | n/a | 1.44M | 1.5M |
Selling & Marketing Expenses | n/a | n/a | n/a | -452K | n/a | -770K |
Cost & Expenses | 96.82M | 93.62M | 50.96M | 49.39M | 36.93M | 28.96M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 153.37M | 43.54M | 47.61M | 47.61M | 47.61M | 47.61M |
Shares Outstanding (Diluted) | 153.37M | 43.54M | 47.61M | 47.61M | 47.61M | 47.61M |
EPS (Basic) | -0.92 | -1.62 | -1.98 | -1.34 | -1.12 | -0.86 |
EPS (Diluted) | -0.92 | -1.62 | -1.98 | -1.34 | -1.12 | -0.86 |
EBITDA | -139.83M | -68.02M | -76.81M | -46M | -36.62M | -28.19M |
EBIT | -140.95M | -68.69M | -77.09M | -46.45M | -37.29M | -28.96M |
Depreciation & Amortization | 1.13M | 677K | 286K | 452K | 676K | 770K |
Add to Watchlist
Select watchlists to add or remove GUTS